No Detail Found!

Assessment of biofilm forming capability and antibiotic resistance in Proteus mirabilis colonizing indwelling catheter

Author(s)
Olivia Sochi Egbule, Department of Microbiology, Delta State University, Abraka, Nigeria
Omenogor Patricia Konye Department of Nursing Science, Delta State University, Abraka, Nigeria
Benson Chuck Iweriebor Sefako Makgatho Health Sciences University, Ga-Rankuwa, South Africa
Abstract
Backgrounadnd Objective: Urinary tract infect ifroomnsthe use of anindwelling urinary catheter are one of the most common infections caused by Proteus mirabilis. Due to their biofilm-producing capacity and the increasing antimicrobial resistance in this microorganism, this study aimed to determine the prevalence, biofilm-producing capacity, antimicrobial resistance patterns, multidrug resistance and plasmid mediated resistance of the recovered isolates. Materials and Methods: A total of 50 urinary samples were collected from Mayto August, 2018 from patients on indwellingurinary catheters. Using routine microbiol ogical and biochemical methods, 37 2. mirabilis were isolated. Biofilm forming capability was determined among the isolates using the tube method while antimicrobial susceptibility and plasmid curing were also performed. Results: Al isolates were biofilm producers with 17(46%) being moderate producers while 20(54%) were strong biofilm formers. The study isolates exhibited a high resistance rate to empiric antibiotics, including ceftazidime (75.8%), cefuroxime (54.5%), ampicillin (69.7%) and amoxicillin-clavulanic acid (51.5%). Low resistancwaes seen in the fluoroguinolones, gentamicinand nitrofurantoin. Plasmid curing experiment revealed that mostisolates lost their resistance indicating thatresistance was borne on plasmids. Plasmid carriage s likely the reason for the high MDR rate of 56.8% observed. Conclusion: These findings necessitate the provision of infection control programs which will guide and implement policies.
Publication Details
Page(s) 268-275
Published Journal: Pakistan Journal of Biological Sciences, Volume: 27, Issue: 5, Year: 2024

Request the full text from PASTIC

Keywords
resistance, multi-drug resistance, Urinary tract infection, plasmid, Proteus mirabilis, biofilm formation/production
References
Jamil RT,Foris L.A.,Snowden J. .2023 .Proteus mirabilis Infections. StatPearls Publishing, : .
Oztiirk R.,Murt A. .2020 .Epidemiology of urological infections: A global burden. World J. Urol,, 38 : 2669-2679.
Jacobsen S.M,,DJ M.E.,Shirtliff M.E. .2008 .Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. , : .
Clin. Microbiol. Rev. . .. , 21 : 26-59.
Morris N.S.,DJ C.,Winters C.,Urol J. .1997 .Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? Br. , 80 : 58-63.
Wasfi L.,Fahmy L. .2020 .. , : .
. .Proteus mirabilis biofilm: Development and therapeutic strategies. Front. Cell. Infect. Microbiol, 10 : .
.2020 .. , 00414 : .
Hamilton A.L,M.A. Kamm S.C.,Ng M.,Morrison M. .2018 .. , : .
Clin. Microbiol. Rev, . .. , 31 : 17.
Drzewiecka D. .2016 .Significance and roles of Proteus spp. , : .
. .bacteria in natural environments. , 72 : 741-758.
Flemming H.C.,J. Wingender H.C. .2010 .The biofilm matrix. , : .
Nat. Rev. Microbiol. . .. , : 623-633.
Jones G.L,AD. Russell Z,Caliskan D.J.,Stickler D.J. .2005 .. , : .
. .A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan. Eur. Urol., 48 : 838-845.
. Chen Y.H.,Chen P.L.,Lu T.C.,Chen C.Y.,Lin C.Y. .2012 .Proteus mirabilis urinary tract infection and bacteremia: Riskfactors, clinical presentation, and outcomes. , : .
Microbiol J. . .. , 45 : 228-236.
Ferraro M.J. .2009 .Antimicrobial susceptibility testing: Areview of general principles and contemporary practices. Clin. Infect. Dis., 49 : 1749-1755.
. Harika K.,Shenoy V.P.,Narasimhaswamy N.,Chawla K. .2020 .Detection of biofilm production and its impact on antibiotic resistance profile of bacterial isolates from chronic wound infections. J. Global Infect. Dis., 12 : 129-134.
Berman M.L.,Enquist L.W. .1984 .Experiments with Gene Fusions. , 9780879691639 : 303.
. Serry F.M.,HK F.M.,Abdel-Latif S.E.,Gomaa H.A.,Abbas H.A. .2018 .. , : .
. .Antimicrobial resistance of clinical Proteus mirabilis isolated from different sources. Zagazig J. Pharm. Sci.,, 27 : 57-63.
. Schaffer J.N.,M.M. Pearson J.N. .2015 .Proteus mirabilis and urinary tract infections. Microbiol. Spectr, 3 : .
.2013 .. , : .
.2019 .Proteus mirabilis Overview. Methods and Protocols, (8) : 1-4.
. Kishore .2012 .identification & characterization of Proteus penneri-A missed rare pathogen. Indian J. Med. Res., 135 : 341-345.
. Pandey A,Madan M. .2014 .. , : .
. .Extended spectrum beta lactamase producing Proteus pennerr. Arare missed pathogen? Indian J. Pathol. Microbiol., 57 : 489-491.
. Cohen-Nahum K,Saidel-Odes K.,Riesenberg F.,Schlaeffer A.,Borer A. .2010 .Urinary tract infections caused by multi-drug resistant Proteus mirabilis: Risk factors and clinical outcomes. Infection, 38 : 41-46.
Okesola A.O.,Adeniji T.W. .2010 .Pattern of extended spectrum beta-lactamase production among clinical isolates of Proteus species in Western Nigeria. World J. Med. Sci,, 5 : 94-97.
Obadire S.,Mitsan L.P.,Ige D.,Ugbomoiko D.,Odewusi O.C.,Oke O.C. .2022 .Prevalence and antibiotic susceptibility pattern of Proteus species isolated from clinical specimens from selected hospitals in Jigawa State, North-West Nigeria. , 0 : .
Med Sokoto J. . .. , 7 : 27-34.
Alabi ,Mendonga N.,Adeleke O.E.,G.J. da Silva O.E. .2017 .. , 0 : .
. .Molecular screening of antibiotic-resistant determinants among multidrug-resistant clinical isolates of Proteus mirabilis from SouthWest Nigeria. Health Sci, 17 : 356-365.
Adamus-Bialek W .2013 .. Kaca, : .
Mol. Biol. Rep. . .. , 40 : 3429-3435.
Maione A,Cirillo L.,Gambino E.,Gallo M.A. .2023 .Prevalence, resistance patterns and biofilm production ability of bacterial uropathogens from cases of community-urianarcytqrauctiinfrecteiodnsin South Italy. Pathogens, 12 : .
Fusco A,Coretti L,Savio V.,Buommino E.,Lembo F.,Donnarumma G. .2017 .Biofilm formation and immunomodulatory activity of Proteus mirabilis clinically isolated strains. Int.J.Mol. Sci, 18 : .
Jacobsen S.M.,ME. Shirtliff S.M. .2011 .Proteus mirabilis biofilms and catheter-associated urinary tract infections. , : .
Virulence . .. , 2 : 460-465.
Kim J.Y,Park Y.J.,S.I. Kim Y.J.,Lee S.0.,Lee K.Y.,Antimicrob K.Y. .2004 .Nosocomial outbreak by Proteus mirabilis producing extended-spectrum B-lactamaseVEB-1 in a Korean university hospital. , 54 : 1144-1147.
Sun S.,Wen L.,Zhao Q.,Xia Y.,Pan Y. .2020 .. , : .
Vet. Res BMC . .. , 16 : 512917.
Egbule O.S.,Ehwarieme A.D.,Owhe-Ureghe A.D. .2016 .. , : .
. .High rate of antibiotic resistance in a neonatal intensive care unit of a university hospital. Microbiol. Res. J. Int,, 15 : .
.2016 .. , : .
Egbule ,UB. .2016 .Owhe-Ureghe and EE. , 0 : .
. .Occurrence of multidrug resistance among £ coli 0157:H7 isolated from stool samples obtained from hospitalized children. J. Probiotics Health, 4 : .
Egbule .2019 .Multiple antibiotic resistances in Escherichia coliisolated from cattle and poultry faeces in Abraka, South-South Nigeria. Pertanika J. Trop. Agric. Sci., 42 : 585-594.
Egbule .2022 .Occurrence of extended spectrum beta-lactamases and Su/1in multi-drug resistant £scherichia coli and Salmonella isolated from poultry feeds. Sci. Afr, 18 : .
Algammal AM,Hashem H.R.,Alfifi H.F. Hetta N.S.,Sheraba H.,El-Tarabili H. .2021 .Ramadan and RM. , : .
. .attD gene sequencing, multidrug resistance traits, virulence-determinants, and antimicrobial resistance genes ofemerging XDR and MDR-Proteus mirabilis. Sci.Rep, 11 : .
. .. , : 541598.
Iweriebor B. .2022 .The emergence of colistin-and imipenem-associated multidrug resistance in Escherichia coli isolates from retail meat. Pol.J. Microbiol., 71 : 519-528.
Ye Y,Han Y.,Chen Z.,Liu C.,Ming L. .2018 .. , : .
. .Mechanism for carbapenem resistance of clinical Enterobacteriaceae isolates. Exp. Ther. Med, 15 : 1143-1149.
Alqurashi E,Abulreesh H.H. .2022 .. , : .
. .public health significance. J. Pure Appl, 16 : 1550-1561.
Akortha O.S.,Egbule O.S. .2008 .Transfer of tetracycline resistance gene (tet) between replicons in some enteric bacteria of diarrhoeal origin from some hospitals in South-South, Nigeria. , 7 : 3178-3181.
Egbule .2016 .Antimicrobial resistance and B-lactamase production among hospital dumpsite isolates. J. Environ., : 05.
Prot . .. , 7 : 1057-1063.
Porreca A,D.D'Agostino D.,Romagnoli F. .2021 .The clinical effoifncitraofucranytoin for treating uncomplicated urinary tract infection in adults: A systematic review of randomized control trials. Urol. Int., 105 : 531-540.
van Driel AA,Wijma RA.,Stobberingh E.E.,Verbon A.,CP. Koch B. .2023 .Nitrofurantoin for the treatment of uncomplicated urinary tract infection in female patients: The impact of dosing regimen, age, and renal function on drug exposure. Eur. J. Clin. Pharmacol, 79 : 1043-1049.
Fair Y.,Tor Y. .2014 .Antibiotics and bacterial resistance inthe 21st century. Perspect. Med. Chem, 6 : 25-64.
Shirakawa M.,Kuroda S.,Suzuki M.,Ozawa M. .2020 .IncC plasmids isolated from healthy broilers in Japan. Antimicrob. Agents Chemother, 64 : .
. .. , : 19.
Lakhundi S.,Zhang K. .2018 .Methicillin-resistant Staphylococcusaureus:Molecular characterization, evolution, and epidemiology. Clin. Microbiol. Rev, 31 : .
. .. , : 18.
0

Citations

0

Downloads

83

Views